[CLSTR]
API
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [TECHNOLOGY]

2 clusters · 5 sources · 1 days · First seen · Last updated

AI development in medical and biotechnology sectors

Overview

Recent developments show increased investment in artificial intelligence applications for healthcare and drug development.

BioStack, a healthtech startup, secured $9.5 million in seed funding to build data infrastructure for medical AI. The company focuses on consolidating fragmented clinical information, such as electronic health records and medical imaging, to support its operations in the US, Brazil, Argentina, and India.

In Switzerland, Atlas Bio emerged from stealth with $12.5 million in total funding. The biotech startup is developing an AI foundation model for ‘in silico’ clinical trials, using RNA readout data to simulate drug behavior in virtual patient cohorts to identify safety and efficacy signals before human trials.

Entities

Y Combinator · Basel · Creandum · BioStack · Atlas Bio

Timeline

  1. [TECHNOLOGY] 2 sources
    Atlas Bio raises $12.5M to simulate drug trials using AI

    Swiss startup Atlas Bio secured $12.5M to develop AI foundation models that simulate clinical trials, aiming to reduce the 70% failure rate seen in Phase II drug development.

  2. [TECHNOLOGY] 2 sources
    BioStack raises $9.5 million for medical AI data infrastructure

    BioStack has raised $9.5 million in seed funding to develop proprietary datasets for medical AI, targeting expansion in the US, India, Brazil, and Argentina.

Sources

inc42.com · pulse2.com · tech.eu · techfundingnews.com · tezzbuzz.com